PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 07 2025
0mins
Should l Buy ?
Source: Businesswire
Investigation of Proposed Sale: Former Louisiana Attorney General Charles C. Foti, Jr. and Kahn Swick & Foti, LLC are investigating the merger of Predictive Oncology Inc. with Renovaro Inc., focusing on whether the proposed exchange of stock adequately values Predictive Oncology.
Legal Rights Inquiry: KSF is inviting shareholders who believe the transaction undervalues the company to discuss their legal rights and options for recourse, providing contact information for inquiries.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
